Complete versus culprit-only strategy in older MI patients with multivessel disease

Simone Biscaglia1, Andrea Erriquez1, Matteo Serenelli1

  • 1Cardiovascular Institute, Azienda Ospedaliero-Universitaria di Ferrara, Cona (FE), Ferrara, Italy.

Insights

For older patients with myocardial infarction (MI) and multivessel disease (MVD), complete revascularization significantly lowers mortality and repeat heart attack rates compared to culprit-only treatment. This finding suggests a potentially better strategy for this vulnerable population.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Clinical Outcomes Research

Background:

  • Optimal revascularization strategy for older patients (≥75 years) with myocardial infarction (MI) and multivessel disease (MVD) remains unclear.
  • Current guidelines often default to a culprit-only approach in this demographic.

Purpose of the Study:

  • To compare the effectiveness of complete revascularization versus culprit-only revascularization in older MI patients with MVD.
  • To evaluate the impact on all-cause mortality, cardiovascular death, MI, and major bleeding.

Main Methods:

  • Retrospective analysis of merged data from four registries.
  • Inclusion criteria: age ≥75 years, MI, MVD, successful culprit lesion treatment.
  • Propensity score matching and inverse probability of treatment weighting (IPTW) were used for multivariable adjustment.

Main Results:

  • 2087 patients included; 725 (35%) underwent complete revascularization, 1362 (65%) culprit-only.
  • Adjusted 1-year all-cause mortality was lower in the complete revascularization group (9.7%) versus culprit-only (12.9%).
  • Complete revascularization was associated with significantly lower rates of cardiovascular death and MI.

Conclusions:

  • Complete revascularization in older MI patients with MVD is associated with reduced all-cause and cardiovascular mortality.
  • The findings suggest that complete revascularization may be a superior strategy over culprit-only treatment for this patient group.
  • Further dedicated trials are warranted to confirm these outcomes.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
53
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
36
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.7K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
72